CD4 and invasive breast carcinoma: Single-cell data analysis revealed that DRGs were predominantly expressed in CD4+ conventional T-cells and regulatory T-cells.<h4>Conclusion</h4>This study has successfully developed a prognostic signature for DRGs, which can be utilized as an efficient tool for risk stratification and prognostic prediction in BRCA patients.